Support women in science at Burnet Institute
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
13 October, 2021
This is an excerpt from an article written for the Australian National University’s Devpolicy Blog by Burnet Institute’s Professor Brendan Crabb AC and Professor Mike Toole AM. Read the original article here.
On Monday, the ‘End COVID for All’ coalition launched its report A Shot of Hope: Australia’s role in vaccinating the world against COVID-19.
On the same day, the New York Times reported that around 48 per cent of the world’s population had received at least one dose of a COVID-19 vaccine. However, the rate was 100 times lower in low income countries.
And, at 155 times worse, the discrepancy between doses given in high and upper-middle income countries (77 per cent one dose) vs low income countries (0.5 per cent) is even starker.
Globally, around 23 low income countries have such low rates of vaccination that, on current rates, they would not vaccinate 70 per cent of their populations until after 2030.
The COVID-19 pandemic has had far reaching impacts. It is the biggest health, economic and societal disruption since World War II. Even countries that have had very few COVID-19 cases, such as some Pacific Island countries, have suffered substantially from the effects on tourism, trade and remittances.
Papua New Guinea is enduring a third wave that is probably more severe than at any time since the pandemic began.
The true number of cases is probably much higher than the official figures, given the low testing rates.
Now that the pace of vaccinations in Australia is rapidly increasing, and Sydney, Canberra and Melbourne face the prospect of soon coming out of lockdowns, it is time to look outwards and demonstrate the generosity that has been the hallmark of Australian responses to previous global crises.
A fast evolving respiratory infection cannot simply be pushed to the poorer sidelines, as has been the case for other pandemics like HIV and tuberculosis.
Ending COVID-19 everywhere is not just an ethical imperative, it is essential for a healthier, more open, and economically stronger Australia.
Read the original article here.
For more information in relation to this news article, please contact:
Director and CEO; Co-Head Malaria Research Laboratory; Chair, Victorian Chapter of the Association of Australian Medical Research Institutes (AAMRI)